Germany· DE-A57-0d36a1dc36788535
Sativex
A medicinal product containing dronabinol, cannabidiol, registered in Germany by Cnx Therapeutics Ireland Limited.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dronabinol, Cannabidiol
- Manufacturer
- Cnx Therapeutics Ireland Limited
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dronabinol, cannabidiol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwaySativex2care4 ApS
- SpainSATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCALCnx Therapeutics Ireland Limited
- United KingdomSativex oromucosal spraySVX Therapeutics Ltd
- IrelandSativex oromucosal sprayCNX Therapeutics Ireland Limited
- IcelandSativexCNX Therapeutics Ireland Limited
- NetherlandsSativex, spray voor oromucosaal gebruikCNX Therapeutics Ireland Limited
- CanadaSATIVEXJAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
- PolandSativexCNX Therapeutics lreland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Sativex
- Belgium · Sativex
- Czechia · Sativex
- Denmark · Sativex
- Spain · Sativex
- Finland · Sativex
- France · Sativex
- United Kingdom (Northern Ireland) · Sativex
- Greece · Avidekel/ Tikun, Capjera
- Iceland · Sativex
- Luxembourg · Sativex
- Netherlands · Sativex
- Norway · Sativex
- Slovakia · Sativex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d77a0f4b-ecd6-4342-83c5-21f04b6c4b7c GET /v1/drugs/d77a0f4b-ecd6-4342-83c5-21f04b6c4b7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oromucosal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dronabinol, Cannabidiol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dronabinol, cannabidiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.